Logo image of EXPO

EXPONENT INC (EXPO) Stock Fundamental Analysis

NASDAQ:EXPO - Nasdaq - US30214U1025 - Common Stock - Currency: USD

71.34  -1.17 (-1.61%)

After market: 71.34 0 (0%)

Fundamental Rating

6

EXPO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. Both the health and profitability get an excellent rating, making EXPO a very profitable company, without any liquidiy or solvency issues. EXPO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year EXPO was profitable.
In the past year EXPO had a positive cash flow from operations.
EXPO had positive earnings in each of the past 5 years.
Each year in the past 5 years EXPO had a positive operating cash flow.
EXPO Yearly Net Income VS EBIT VS OCF VS FCFEXPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1.2 Ratios

EXPO has a better Return On Assets (13.82%) than 90.24% of its industry peers.
With a decent Return On Equity value of 23.90%, EXPO is doing good in the industry, outperforming 76.83% of the companies in the same industry.
The Return On Invested Capital of EXPO (15.56%) is better than 82.93% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXPO is significantly above the industry average of 12.28%.
Industry RankSector Rank
ROA 13.82%
ROE 23.9%
ROIC 15.56%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
EXPO Yearly ROA, ROE, ROICEXPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 18.87%, EXPO belongs to the top of the industry, outperforming 89.02% of the companies in the same industry.
EXPO's Profit Margin has been stable in the last couple of years.
The Operating Margin of EXPO (23.84%) is better than 90.24% of its industry peers.
In the last couple of years the Operating Margin of EXPO has remained more or less at the same level.
EXPO's Gross Margin of 92.78% is amongst the best of the industry. EXPO outperforms 98.78% of its industry peers.
In the last couple of years the Gross Margin of EXPO has remained more or less at the same level.
Industry RankSector Rank
OM 23.84%
PM (TTM) 18.87%
GM 92.78%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
EXPO Yearly Profit, Operating, Gross MarginsEXPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXPO is creating value.
The number of shares outstanding for EXPO has been increased compared to 1 year ago.
EXPO has less shares outstanding than it did 5 years ago.
There is no outstanding debt for EXPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXPO Yearly Shares OutstandingEXPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EXPO Yearly Total Debt VS Total AssetsEXPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 9.81 indicates that EXPO is not in any danger for bankruptcy at the moment.
EXPO has a Altman-Z score of 9.81. This is amongst the best in the industry. EXPO outperforms 95.12% of its industry peers.
There is no outstanding debt for EXPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.81
ROIC/WACC1.71
WACC9.08%
EXPO Yearly LT Debt VS Equity VS FCFEXPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

EXPO has a Current Ratio of 3.32. This indicates that EXPO is financially healthy and has no problem in meeting its short term obligations.
EXPO has a Current ratio of 3.32. This is amongst the best in the industry. EXPO outperforms 89.02% of its industry peers.
A Quick Ratio of 3.32 indicates that EXPO has no problem at all paying its short term obligations.
The Quick ratio of EXPO (3.32) is better than 90.24% of its industry peers.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 3.32
EXPO Yearly Current Assets VS Current LiabilitesEXPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.54% over the past year.
Measured over the past 5 years, EXPO shows a small growth in Earnings Per Share. The EPS has been growing by 6.74% on average per year.
The Revenue has been growing slightly by 3.27% in the past year.
Measured over the past years, EXPO shows a small growth in Revenue. The Revenue has been growing by 6.01% on average per year.
EPS 1Y (TTM)3.54%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%-11.86%
Revenue 1Y (TTM)3.27%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%0.17%

3.2 Future

Based on estimates for the next years, EXPO will show a small growth in Earnings Per Share. The EPS will grow by 2.98% on average per year.
Based on estimates for the next years, EXPO will show a small growth in Revenue. The Revenue will grow by 5.35% on average per year.
EPS Next Y-5.38%
EPS Next 2Y1.55%
EPS Next 3Y2.98%
EPS Next 5YN/A
Revenue Next Year3.02%
Revenue Next 2Y5.09%
Revenue Next 3Y5.35%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
EXPO Yearly Revenue VS EstimatesEXPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
EXPO Yearly EPS VS EstimatesEXPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 34.80 indicates a quite expensive valuation of EXPO.
62.20% of the companies in the same industry are cheaper than EXPO, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.46. EXPO is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 32.63, the valuation of EXPO can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXPO indicates a slightly more expensive valuation: EXPO is more expensive than 63.41% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.44. EXPO is around the same levels.
Industry RankSector Rank
PE 34.8
Fwd PE 32.63
EXPO Price Earnings VS Forward Price EarningsEXPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

EXPO's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXPO is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 26.98
EV/EBITDA 24
EXPO Per share dataEXPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

EXPO has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)5.16
EPS Next 2Y1.55%
EPS Next 3Y2.98%

6

5. Dividend

5.1 Amount

EXPO has a Yearly Dividend Yield of 1.62%. Purely for dividend investing, there may be better candidates out there.
EXPO's Dividend Yield is rather good when compared to the industry average which is at 2.11. EXPO pays more dividend than 80.49% of the companies in the same industry.
EXPO's Dividend Yield is slightly below the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.62%

5.2 History

On average, the dividend of EXPO grows each year by 28.57%, which is quite nice.
EXPO has paid a dividend for at least 10 years, which is a reliable track record.
EXPO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)28.57%
Div Incr Years11
Div Non Decr Years11
EXPO Yearly Dividends per shareEXPO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

EXPO pays out 55.92% of its income as dividend. This is a bit on the high side, but may be sustainable.
EXPO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP55.92%
EPS Next 2Y1.55%
EPS Next 3Y2.98%
EXPO Yearly Income VS Free CF VS DividendEXPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EXPO Dividend Payout.EXPO Dividend Payout, showing the Payout Ratio.EXPO Dividend Payout.PayoutRetained Earnings

EXPONENT INC

NASDAQ:EXPO (7/21/2025, 8:00:01 PM)

After market: 71.34 0 (0%)

71.34

-1.17 (-1.61%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners95.82%
Inst Owner Change0.23%
Ins Owners0.93%
Ins Owner Change2.24%
Market Cap3.62B
Analysts77.78
Price Target93.84 (31.54%)
Short Float %3.9%
Short Ratio6.13
Dividend
Industry RankSector Rank
Dividend Yield 1.62%
Yearly Dividend1.07
Dividend Growth(5Y)28.57%
DP55.92%
Div Incr Years11
Div Non Decr Years11
Ex-Date06-06 2025-06-06 (0.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.01%
Min EPS beat(2)6.21%
Max EPS beat(2)11.81%
EPS beat(4)4
Avg EPS beat(4)7.79%
Min EPS beat(4)2.12%
Max EPS beat(4)11.81%
EPS beat(8)5
Avg EPS beat(8)4.91%
EPS beat(12)8
Avg EPS beat(12)5.53%
EPS beat(16)12
Avg EPS beat(16)6.6%
Revenue beat(2)2
Avg Revenue beat(2)0.71%
Min Revenue beat(2)0.08%
Max Revenue beat(2)1.35%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-2.41%
Max Revenue beat(4)1.35%
Revenue beat(8)5
Avg Revenue beat(8)1.06%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-14.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.52%
Valuation
Industry RankSector Rank
PE 34.8
Fwd PE 32.63
P/S 6.48
P/FCF 26.98
P/OCF 25.61
P/B 8.2
P/tB 8.37
EV/EBITDA 24
EPS(TTM)2.05
EY2.87%
EPS(NY)2.19
Fwd EY3.06%
FCF(TTM)2.64
FCFY3.71%
OCF(TTM)2.79
OCFY3.9%
SpS11.02
BVpS8.7
TBVpS8.53
PEG (NY)N/A
PEG (5Y)5.16
Profitability
Industry RankSector Rank
ROA 13.82%
ROE 23.9%
ROCE 21.06%
ROIC 15.56%
ROICexc 25.39%
ROICexgc 25.97%
OM 23.84%
PM (TTM) 18.87%
GM 92.78%
FCFM 24%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
ROICexc(3y)30.54%
ROICexc(5y)30.82%
ROICexgc(3y)31.45%
ROICexgc(5y)31.86%
ROCE(3y)25.12%
ROCE(5y)22.78%
ROICexcg growth 3Y-10.75%
ROICexcg growth 5Y-4.18%
ROICexc growth 3Y-10.36%
ROICexc growth 5Y-3.84%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 73.16%
Cap/Sales 1.29%
Interest Coverage 250
Cash Conversion 98.77%
Profit Quality 127.16%
Current Ratio 3.32
Quick Ratio 3.32
Altman-Z 9.81
F-Score5
WACC9.08%
ROIC/WACC1.71
Cap/Depr(3y)141.73%
Cap/Depr(5y)120.6%
Cap/Sales(3y)2.21%
Cap/Sales(5y)1.87%
Profit Quality(3y)105.59%
Profit Quality(5y)110.44%
High Growth Momentum
Growth
EPS 1Y (TTM)3.54%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%-11.86%
EPS Next Y-5.38%
EPS Next 2Y1.55%
EPS Next 3Y2.98%
EPS Next 5YN/A
Revenue 1Y (TTM)3.27%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%0.17%
Revenue Next Year3.02%
Revenue Next 2Y5.09%
Revenue Next 3Y5.35%
Revenue Next 5YN/A
EBIT growth 1Y18.03%
EBIT growth 3Y3.15%
EBIT growth 5Y7.03%
EBIT Next Year26.28%
EBIT Next 3Y11.81%
EBIT Next 5YN/A
FCF growth 1Y71.24%
FCF growth 3Y5.33%
FCF growth 5Y10.11%
OCF growth 1Y51.28%
OCF growth 3Y5.08%
OCF growth 5Y5.99%